Superworth

BeOne Medicines price to free cash flow ONC

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Nov 3, 2026
30.2×
Peer median
23.7×

BeOne Medicines' price to free cash flow is 30.2× as of Nov 3, 2026.

The median for 10 biotech stocks of a similar size is 23.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far30.9×26.4×73.6×
202563.5×63.5×155×

Against its peers

Companies in Biotechnology nearest BeOne Medicines' size, closest first, today.

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on BeOne Medicines

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.